LEGN - Financial Reports List - Legend Biotech Corporation - IntrinsicAlpha

Legend Biotech Corporation LEGN

Healthcare - Biotechnology - NASDAQ - US

$ 34.48

-1.71 %

$ 3.17 B

Market Cap

-33.58

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	134.73%	118.15%	38.54%
Annual Report	FY	10-K	2024-12-31	119.97%	65.84%	31.00%
Quarterly Report	Q3	8-K	2024-09-30	66.86%	-101.46%	100.00%
Quarterly Report	Q2	8-K	2024-06-30	154.36%	90.86%	53.14%
Quarterly Report	Q1	8-K	2024-03-31	158.67%	46.66%	-10.30%
Quarterly Report	Q4	8-K	2023-12-31	187.57%	-6.58%	-37.92%
Annual Report	FY	10-K	2023-12-31	143.70%	-16.11%	3.59%
Quarterly Report	Q3	8-K	2023-09-30	250.91%	26.78%	53.07%
Quarterly Report	Q2	8-K	2023-06-30	512.56%	-3.05%	25.67%
Quarterly Report	Q1	8-K	2023-03-31	-11.00%	-166.39%	-42.49%

1